Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.

The FDA approved Novavax's COVID-19 vaccine, Nuvaxovid, this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

The FDA has approved Moderna’s next-generation COVID-19 vaccine for people older than 65. REUTERS “The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect ...

Panel members also voted to recommend an additional COVID-19 vaccine for people 65 and older. Here’s what older adults should know about the changes to the CDC panel's recommendations.

Hospitalization rates for flu — the study’s primary outcome — were 69.5 vs 90.5 per 100,000 person-years in the HD vs standard-dose group. This represented a 23.3% reduction (95% CI, 8.4-35. ...